Scribd Logo
Upload

Welcome to Scribd!

  • 34 views

    Announces Q3 Results (Standalone), Limited Review Report (Standalone) & Results Press Release For The Quarter Ended December 31, 2015 (Result)

    Uploaded by

    Shyam Sunder
    Divi's Laboratories Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2015. For the quarter, the company reported a profit after tax of Rs. 247 crores on total income of Rs. 853 crores. For the nine month period, total income was Rs. 2626 crores and profit after tax was Rs. 785 crores. The auditor, P.V.R.K. Nageswara Rao & Co., stated in their limited review report that nothing had come to their attention to suggest the results contained any material misstatements.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Announces Q3 Results (Standalone), Limited Review Report (Standalone) & Results Press Release For The Quarter Ended December 31, 2015 (Result)

    Uploaded by

    Shyam Sunder
    34 views5 pages
    Divi's Laboratories Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2015. For the quarter, the company reported a profit after tax of Rs. 247 crores on total income of Rs. 853 crores. For the nine month period, total income was Rs. 2626 crores and profit after tax was Rs. 785 crores. The auditor, P.V.R.K. Nageswara Rao & Co., stated in their limited review report that nothing had come to their attention to suggest the results contained any material misstatements.

    Original Title

    Announces Q3 Results (Standalone), Limited Review Report (Standalone) & Results Press Release for the Quarter ended December 31, 2015 [Result]

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Divi's Laboratories Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2015. For the quarter, the company reported a profit after tax of Rs. 247 crores on total income of Rs. 853 crores. For the nine month period, total income was Rs. 2626 crores and profit after tax was Rs. 785 crores. The auditor, P.V.R.K. Nageswara Rao & Co., stated in their limited review report that nothing had come to their attention to suggest the results contained any material misstatements.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    34 views5 pages

    Announces Q3 Results (Standalone), Limited Review Report (Standalone) & Results Press Release For The Quarter Ended December 31, 2015 (Result)

    Uploaded by

    Shyam Sunder
    Divi's Laboratories Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2015. For the quarter, the company reported a profit after tax of Rs. 247 crores on total income of Rs. 853 crores. For the nine month period, total income was Rs. 2626 crores and profit after tax was Rs. 785 crores. The auditor, P.V.R.K. Nageswara Rao & Co., stated in their limited review report that nothing had come to their attention to suggest the results contained any material misstatements.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 5

    @~~

    Divi's Laboratories Limited

    Date. 5 th February 2016


    The Secretary

    BSE Limited

    1st Floor, New Trading Ring, Rotunda Bldg.,

    PJ. Towers, Dalal Street, Fort

    MUMBAI - 400 023

    Dear Ir,

    Sub: Un-audited financial results for the quarter and nine months ended
    31 st December 2015 and limited review report -reg
    Ref: Stock code: 532488
    Pursuant to Regulation 33 of

    ' . . B[ (Listing Obligations and Disclosure

    Requirements) Regulation, 2015, please find enclosed un-audited financial results


    along with the limited review report [or the quarter and nine months ended 31 5t
    Dec mber 2015.
    Above un-aud ited financials were approved and taken on record by the Board of
    Directors o[the Company at their meeting held on Friday, 5th February 20 16.
    The Company proposes release of press note as per the enclosed format. This is
    for your information and r cords. Kindly acknowledge the receipt of the same.
    Thanking You,
    Yours faithfully,

    For Divi's Laboratories Limited

    i2. '
    L-
    P V ~C>a~shmi Rajani

    .""IoJ

    Company Secretary

    (ACS 18882)

    CIN : L2411 OTG 1990PLC011854

    "An ISO-9001, 150-14001 and OHSAS-18001 Triple certified company"


    Regd. Off: Divi Towers, 7-1-771Fl1/303, Dharam Karan Road, Ameerpet, Hyderabad - 500 016. INDIA

    Tel: 91-40-23786300, Fax: 91-40-2378 6460

    E-mail: [email protected], Website: www.divislabomtories.com

    DIVI'S LABORATORIES LIMITED


    UN-AUDIl ED FINA CIAL RESULTS (Sr ANDA LONE )
    FOR TILE QUARTER A D NINE ONTIIS ENDED 31" DECEMBER. 20 15

    (Rs.in Lakbs)
    Particulars

    Quarter ended

    (I )
    I

    Income from operations


    (a) Net Sales/Income from
    o[lerations (Net of Excise Dul)')
    (b) Other Operat ing Income
    Total rncome from operations
    (net)
    Expenses

    a. Cost o f materials consumed


    h. Purchases of stock-in-trade
    c. Changes in in ven t ries of
    l1 nished good " work-i n
    progress and slock-in-trade
    d. Emplo ee benetits expense
    c. Depreciation and amortizatio n
    expense
    r. Other Expenses
    Total Expenses

    4
    5

    8
    \}

    Profit from Operations before


    Olher Income, Finance Costs &
    Exceptional Items (1-2)
    Other Income
    Pro lit from ordinary activities
    before flnnnce costs & exceptional
    Uems (3+4)
    r inant:e Costs
    Prolit from ordinary activities
    after linance costs but before
    exceptionnlltems (5-6)
    Exc\![lliona l items
    Profit from ordinary activities
    before Tax (7-8)

    10

    rax Expense

    II

    Net Profit from ordinary activitie


    after Tax (9- 10)
    E'lra-ordinary itcms (net of tax
    expcnse)
    Net Profit (+)/Loss(-) for the
    period (11-12)
    Pai d-u p Equity Share Capital
    (face Value : Rs.2 per share)

    12

    13
    14

    STANDALONE
    Nine Monlhs ended

    31.12.2015

    30.09.2015

    31.12.20 14

    31.12.2015

    31.12.2014

    Year
    Ended
    31.03.2015

    Unaudited
    (2)

    Unaudited
    (3 )

    Unaud ited

    Unaudited

    (4)

    (5)

    Unaudited
    (6)

    Audited
    (7)

    85177

    96187

    78808

    262055

    225 761

    307230

    110
    85287

    245
    96432

    304
    79 112

    540
    262595

    93J
    226692

    1171
    308401

    33258
    0
    (1512)

    42106

    34672

    105441

    (3571 )

    (2808)

    110931
    0
    (8596)

    144627
    0
    (23083)

    9118
    2988

    8595
    3007

    7459
    2879

    25746
    8887

    20425
    9131

    283 15
    13585

    12194
    56046
    29241

    11702
    61839
    34593

    11080
    53282
    25830

    34700
    ]71668
    90927

    31546
    152917
    73775

    42337
    205781
    102620

    1520
    30761

    2964

    37557

    1994
    27824

    7883
    98810

    481 7
    78592

    4284
    106904

    23
    30738

    34
    37523

    48
    27776

    79
    98731

    1. 27
    78465

    186
    106718

    0
    30738

    0
    37523

    0
    27776

    0
    98731

    0
    78465

    0
    106718

    6082
    24656

    7950
    295 73

    5718
    22058

    20184
    78547

    16650
    61815

    22012
    84706

    24656

    29573

    22058

    78547

    61815

    84706

    5309

    5309

    2655

    5309

    2655

    2655

    ( 13626)

    15
    16

    Reserves excluding revaluation


    rese rves as per balance sheet of
    previous accounting year
    Earnings per Share
    (of Rs.21- each) (not annualized):
    a) Basic
    b) Diluted

    35354 1
    9.29
    9.29

    11. 14
    1 1. 14

    8.3 1
    8.3 1

    29.59
    29.59

    23.29
    23.29

    31.91
    3 1.9 1

    NOTES:

    I . The above results for the quarter ended 31 '1Dece mber 2015, as reviewed by the Audit Comm ittee, were considered and
    approved by the Board of Directors at its meeting held on Sd1 February, 2016 and were subjected to ' limited review' by
    the Auditors.
    2. The Company is primarily engaged in the man ufacture of Active Pharmaceutical Ingredients and intennediates.
    Accordingly there are no reportable segments as p r Accounting Standard 17 notified under the Compan ies Act, 1956.
    3. The company has opted to publish quarter ly unaud ited standalone resul ts and to publish consol idated results at the year
    end.
    4. Detal'1so f ftorex gam
    . /I oss are gIven beow:
    I
    Rs.m
    . L a kh

    ' s
    Quarter
    ended
    Nine
    Months
    ended
    Particulars
    Year
    Ended

    31.12.20 14
    3 1. 12.20 14
    31 .03.201 5
    31.12.2015
    Unaudited
    Unaudi ted
    Unaudited
    Unaudited
    Unaudited
    Audited
    1683
    ( lOS)
    294
    1166
    1116
    3582
    For.::x Oain/(Loss)
    Forex gam has been mcluded m Other Income and forex loss has been IIlcluded 111 Other Expenses.
    5. Bonus Issue: The company has allolled 13,27,34,290 bonus shares of Rs.2 each to the members on 281h September.
    2015 . Earnings per Share has bee n adjusted for previous periods presented due to the bonus issue, in accordance with
    Accounting Standard No.20 .
    6. Upon enactment of the Payment of Bonus (Amend ment) Act, 2015 , the company has made add itional provision for
    bonus to employees, during the quart r, amounting to RS.25 7 lakhs for the previous year 20 14- 15.
    7. Figures for the previous year/period have been regrouped or reclassified , wherever necessary.
    31.12.2015

    30.09.2015

    Place: Visakhapatnam
    Date: 05-02-2016
    Chairman & Manag ing Director

    P.VR K. Nageswara Rao & Co.,


    Chartered Accountants
    INDEPENDENT AUDITOR'S REVIEW REPORT

    TO
    THE BOARD OF DIRECTORS OF
    DIVI'S LADORA TORIE LlMlTED
    We haw reviewed the accompanying statement of Standalone Unaudited Financia l
    Result f D1vr's LABORATORlE LIMITED (.. the company") for the quarter Clnd
    s,
    nine months ended 31 December, 2015 ("the tatement"). This statement is the
    respons ibility of the Company's Managemen t and has been approved by the Board f
    Directors. Qur responsibility is to issue a report on the Statement based on our rev iew.
    We conducted Ollr review of the Statement in accordance with the Standard on Review
    Lngugemen ls (SRE) 241 0, . Review of Interim Financial Informat ion Performed by the
    Independen t Auditor of the Entity'. issued by the Institu te of Chartered A(.;cOLll1lanL of
    Ind ia. Thi standard requires that we plan and perform the rev iew LO obtain moderat\!
    a slirance as to whether the Statement is free of material misstatement. A rev iew is
    limited primarily to inquiries of Company personnel and analytical procedures ap plied to
    ti ll uncial data and thu provide less assurance than an alldit. We have no t perform ed an
    audit andaccordingly, we do not express an audit opin ion.
    Based on our review contll! ted as Slated above, nothing has come to ollr allen tio n that
    callses liS to believe that the accompanying Statement, prepared in accordance with th~
    applicable Accounting Standards and other recog nised accounting practices anu polic ies,
    has not di closed the information required to be di closed in terms of Reg ul atio n :1 of lhl:
    SEB I (Listing Obligation and Disclosure Requirements) Reg ulations, 2015 inc lud in g thl.!
    manner in which it is to be disclosed, or that it contains any materia l misstatement.

    For P.V.RK. NAGE WARA RAO & Co.,

    VlSAKH APATNAM
    05.02.2016

    Partner
    Membersh ip Number:23939

    109, Metro Residency I 6-31247, RaJbhavan Road I Khairatabad, Hyderabad - 500082 I India.

    ({) Off. . +91-40-23311609, +91-40-23312269 (Oir) I Fax : +91-402331 9591 I E-mail [email protected]

    DIVI'S LABORATORIES LIMITED


    Hyderabad
    PRESS RELEASE dated 5 th February, 2016

    Divi's Labs earns a PAT of Rs.247 crores in Q3/FY16


    Divi's Laboratories has earned a Profit after Tax (PAT) of Rs.247 crores on
    a total income of RS.853 crores, on a stand-a lone basis, for the quarter
    ended 31 st December, 2015.

    For t he corresponding quarter of the last

    year the company earned a PAT of RS.221 crores on a total income of Rs.
    79

    crores.

    Forex gain for the current quarter amounted to Rs.3 crores as against a
    forex gain of RS.ll crores during the corresponding quarter last year .
    The company has capitalized fixed assets aggregating to RS.34 crores
    duri ng the curre nt quarter.

    For the 9-month period ended 3pt December, 2015, the company earned
    a total income of RS.2626 crores as compared to Rs. 226 7 crores during
    the corresponding 9 - month pe riod of last year .

    PBT for the current 9

    month period came to RS.987 crores as against a PBT of Rs. 785 crores
    for the previous period. PAT for the current 9-months is Rs.785 crores as
    against Rs. 618 crores for the previous period.

    You might also like